Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | SCN4A | P35499 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27904369 | 0.97 | DPP4 (0.48) | DPP4F2ADRA2AADRA2CLMNA | |
| Ethylbenzene SCHEMBL15874120 | 0.85 | TP53 (0.54) | DPP4F2TAAR1 | |
| Benzaldehyde SCHEMBL8037482 | 0.84 | ALDH1A1 (0.52) | DPP4F2ALDH1A1KMT2A | |
| Phenethylamine SCHEMBL10431641 | 0.82 | TAAR1 (0.57) | TAAR1HTR2A | |
| SCHEMBL358554 | 0.78 | DPP4 (0.55) | DPP4F2ADRA2AADRA2CLMNA | |
| SCHEMBL8131172 | 0.75 | ADRA2A (0.46) | DPP4F2ADRA2AADRA2CLMNA | |
| SCHEMBL14344017 | 0.75 | DPP4 (0.59) | DPP4F2ADRA2AADRA2CLMNA | |
| SCHEMBL15149664 | 0.75 | ESR1 (0.48) | LMNAHIF1AKDM4EALDH1A1KMT2A | |
| SCHEMBL9638851 | 0.75 | THRB (0.50) | DPP4F2ADRA2AADRA2CLMNA | |
| SCHEMBL12500605 | 0.75 | CYP1A2 (0.53) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118806962-B | Enzyme-responsive antibacterial hydrogel coating modified medical gauze and preparation method thereof | 浙江大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119595788-A | Biomarker method for predicting curative effect of cyclosporine on aplastic anemia | 宜兴市人民医院 | 2025-03-11 | — | — | CN | claimed |
| CN-118806962-A | Enzyme-responsive antibacterial hydrogel coating modified medical gauze and preparation method thereof | 浙江大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118557747-A | Conjugates of cell binding molecules and camptothecin analogs | 杭州多禧生物科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| US-12024483-B2 | Synthesis method of hydroxybenzylamine | TAIZHOU CHUANGYUAN INDUSTRIAL TECHNOLOGY CO., LTD (CN) | 2024-07-02 | — | — | US | claimed |
| CN-117187133-A | Culture medium for helicobacter pylori separation culture | 苏州长柏生物科技有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-114105983-B | Preparation and application of chiral 1,4,7, 10-tetraaza-2, 6-pyridine cycloparaffin derivative and metal chelate thereof | 国科温州研究院(温州生物材料与工程研究所) | 2023-08-11 | — | — | CN | claimed |
| CN-116082232-A | Monoamine oxidase inhibitor, preparation method and application thereof | 浙江海洋大学 | 2023-05-09 | — | — | CN | claimed |
| US-20220289664-A1 | SYNTHESIS METHOD OF HYDROXYBENZYLAMINE | TAIZHOU CHUANGYUAN INDUSTRIAL TECHNOLOGY CO., LTD (CN) | 2022-09-15 | — | — | US | claimed |
| CN-112190556-B | Compound sulfamethoxazole trimethoprim tablet and preparation method thereof | 河北君临药业有限公司 | 2022-08-12 | — | — | CN | claimed |
| US-6423713-B1 | Substituted pyrazoles as p38 kinase inhibitors | G. D. SEARLE & COMPANY | 2002-07-23 | — | — | US | claimed |
| CN-1323293-A | The preparation of i(N)-substituted-hydroxycycloalkylamine derivatives | SAMSUNG FINE CHEMICALS CO LTD (KR) | 2001-11-21 | — | — | CN | claimed |
| EP-1144403-A1 | SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2001-10-17 | — | — | EP | claimed |
| EP-1114027-A1 | THE PREPARATION OF N-SUBSTITUTED-HYDROXYCYCLOALKYLAMINE DERIVATIVES | Samsung Fine Chemicals Co., Ltd. (KR) | 2001-07-11 | — | — | EP | claimed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | claimed |
| EP-1000055-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. Searle & Co. (US) | 2000-05-17 | — | — | EP | claimed |
| WO-2000015610-A1 | THE PREPARATION OF N-SUBSTITUTED-HYDROXYCYCLOALKYLAMINE DERIVATIVES | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-03-23 | — | — | WO | claimed |
| WO-1998052940-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE AND CO. (US) | 1998-11-26 | — | — | WO | claimed |
| EP-0563145-A1 | CHELATING AGENTS | NYCOMED AS (NO) | 1993-10-06 | — | — | EP | claimed |
| WO-1992011232-A1 | CHELATING AGENTS | NYCOMED IMAGING AS (NO) | 1992-07-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12024483-B2 | Synthesis method of hydroxybenzylamine | HRH4, HRH2, HNMT | DPP4 4230/4885F2 3471/4885ADRA2A 1126/4885 |
| US-20220289664-A1 | SYNTHESIS METHOD OF HYDROXYBENZYLAMINE | HRH4, HRH2, HNMT | DPP4 4230/4885F2 3471/4885ADRA2A 1126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.